Literature DB >> 21907177

Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.

Karen M Kassel1, A Phillip Owens, Cheryl E Rockwell, Bradley P Sullivan, Ruipeng Wang, Ossama Tawfik, Guodong Li, Grace L Guo, Nigel Mackman, James P Luyendyk.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome and contributes to increased risk of cardiovascular disease and liver-related morbidity and mortality. Indeed, obese patients with metabolic syndrome generate greater amounts of thrombin, an indication of coagulation cascade activation. However, the role of the coagulation cascade in Western diet-induced NAFLD has not been investigated. Using an established mouse model of Western diet-induced NAFLD, we tested whether the thrombin receptor protease-activated receptor 1 (PAR-1) and hematopoietic cell-derived tissue factor (TF) contribute to hepatic steatosis. In association with hepatic steatosis, plasma thrombin-antithrombin levels and hepatic fibrin deposition increased significantly in C57Bl/6J mice fed a Western diet for 3 months. PAR-1 deficiency reduced hepatic inflammation, particularly monocyte chemoattractant protein-1 expression and macrophage accumulation. In addition, PAR-1 deficiency was associated with reduced steatosis in mice fed a Western diet, including reduced liver triglyceride accumulation and CD36 expression. Similar to PAR-1 deficiency, hematopoietic cell TF deficiency was associated with reduced inflammation and reduced steatosis in livers of low-density lipoprotein receptor-deficient mice fed a Western diet. Moreover, hematopoietic cell TF deficiency reduced hepatic fibrin deposition. These studies indicate that PAR-1 and hematopoietic cell TF are required for liver inflammation and steatosis in mice fed a Western diet.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907177      PMCID: PMC3204032          DOI: 10.1016/j.ajpath.2011.07.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

2.  Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels.

Authors:  P Fritsch; M Kleber; A Rosenkranz; M Fritsch; W Muntean; H Mangge; T Reinehr
Journal:  Atherosclerosis       Date:  2010-06-23       Impact factor: 5.162

3.  Body composition as determinant of thrombin generation in plasma: the Hoorn study.

Authors:  Hanneke J B H Beijers; Isabel Ferreira; Henri M H Spronk; Bert Bravenboer; Jacqueline M Dekker; Giel Nijpels; Hugo ten Cate; Coen D A Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-16       Impact factor: 8.311

4.  Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors.

Authors:  Marianna D A Gaça; Xiaoying Zhou; R Christopher Benyon
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

Review 5.  A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

Authors:  Claire Z Larter; Shiv Chitturi; Déborah Heydet; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

6.  Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice.

Authors:  Rafal Pawlinski; Jian-Guo Wang; A Phillip Owens; Julie Williams; Silvio Antoniak; Michael Tencati; Thomas Luther; Jesse W Rowley; Elizabeth N Low; Andrew S Weyrich; Nigel Mackman
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

7.  Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers.

Authors:  Bryan L Copple; Frederic Moulin; Umesh M Hanumegowda; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2003-01-24       Impact factor: 4.030

8.  Weight loss reduces tissue factor in morbidly obese patients.

Authors:  Christoph W Kopp; Hans-Peter Kopp; Sabine Steiner; Stephan Kriwanek; Katarzyna Krzyzanowska; Andrea Bartok; Rudolf Roka; Erich Minar; Guntram Schernthaner
Journal:  Obes Res       Date:  2003-08

9.  Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women.

Authors:  Mario Romano; Maria Teresa Guagnano; Giovanni Pacini; Sergio Vigneri; Angela Falco; Marina Marinopiccoli; Maria Rosaria Manigrasso; Stefania Basili; Giovanni Davì
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

10.  Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.

Authors:  Karen M Kassel; Grace L Guo; Ossama Tawfik; James P Luyendyk
Journal:  Lab Invest       Date:  2010-08-09       Impact factor: 5.662

View more
  22 in total

1.  Tissue factor and obesity, a two-way street.

Authors:  Nan Zhang; Daniel A Lawrence
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice.

Authors:  Kazuhisa Miyakawa; Nikita Joshi; Bradley P Sullivan; Ryan Albee; Christina Brandenberger; Hartmut Jaeschke; Mitchell R McGill; Michael A Scott; Patricia E Ganey; James P Luyendyk; Robert A Roth
Journal:  Blood       Date:  2015-07-15       Impact factor: 22.113

3.  Thrombin promotes diet-induced obesity through fibrin-driven inflammation.

Authors:  Anna K Kopec; Sara R Abrahams; Sherry Thornton; Joseph S Palumbo; Eric S Mullins; Senad Divanovic; Hartmut Weiler; A Phillip Owens; Nigel Mackman; Ashley Goss; Joanne van Ryn; James P Luyendyk; Matthew J Flick
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 4.  Coagulation in liver toxicity and disease: role of hepatocyte tissue factor.

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 5.  Tissue factor pathways linking obesity and inflammation.

Authors:  W Ruf; F Samad
Journal:  Hamostaseologie       Date:  2015-01-27       Impact factor: 1.778

Review 6.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

Review 7.  Inflammation, obesity, and thrombosis.

Authors:  Fahumiya Samad; Wolfram Ruf
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

8.  Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

Authors:  Karen M Kassel; Bradley P Sullivan; Wei Cui; Bryan L Copple; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-07-26       Impact factor: 4.307

Review 9.  Role of hemostatic factors in hepatic injury and disease: animal models de-liver.

Authors:  A K Kopec; N Joshi; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2016-05-10       Impact factor: 5.824

10.  From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.

Authors:  Rance Nault; Kelly A Fader; Anna K Kopec; Jack R Harkema; Timothy R Zacharewski; James P Luyendyk
Journal:  Toxicol Sci       Date:  2016-09-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.